These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2056386)

  • 41. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
    Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
    Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
    Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interphase cytogenetics of a male breast cancer.
    Balazs M; Mayall BH; Waldman FM
    Cancer Genet Cytogenet; 1991 Sep; 55(2):243-7. PubMed ID: 1933827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
    Nemoto R; Hattori K; Uchida K; Shimazui T; Koiso K; Harada M
    Br J Urol; 1990 Jan; 65(1):27-31. PubMed ID: 2310929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells.
    Speel EJ; Herbergs J; Ramaekers FC; Hopman AH
    J Histochem Cytochem; 1994 Jul; 42(7):961-6. PubMed ID: 8014480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumor cell line.
    Balazs M; Mayall BH; Waldman FM
    Cancer Genet Cytogenet; 1991 Nov; 57(1):93-102. PubMed ID: 1756490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of DNA in situ hybridization and immunocytochemical detection of nucleolar proteins: a contribution to the functional mapping of the human genome by fluorescence microscopy.
    Leger I; Robert-Nicoud M; Brugal G
    J Histochem Cytochem; 1994 Feb; 42(2):149-54. PubMed ID: 8288860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors.
    Hopman AH; Ramaekers FC; Raap AK; Beck JL; Devilee P; van der Ploeg M; Vooijs GP
    Histochemistry; 1988; 89(4):307-16. PubMed ID: 3410743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preparation and utilization of BrdU antiserum. II. Detections of BrdU labelling chromosome and DNA using BrdU antibody technique].
    Shang K; Lou Z; Wu H
    Yi Chuan Xue Bao; 1992; 19(5):385-9. PubMed ID: 1295535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.
    Tinnemans MM; Schutte B; Lenders MH; Ten Velde GP; Ramaekers FC; Blijham GH
    Br J Cancer; 1993 Jun; 67(6):1217-22. PubMed ID: 8512806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ end labelling of DNA to detect apoptotic cell death in a variety of human tumours.
    Mundle S; Iftikhar A; Shetty V; Alvi S; Dameron S; Gregory S; Marcus B; Khan S; Raza A
    Cell Death Differ; 1994; 1(2):117-22. PubMed ID: 17334328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of DNA-DNA hybridization of dual labeled probes to the detection of trisomy 21, monosomy 21, and sex determination.
    Dahl HH; Choo KH; Danks DM
    Am J Hum Genet; 1988 Oct; 43(4):502-10. PubMed ID: 2972200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new flow cytometric approach to the analysis of DNA and a second parameter.
    Kusuda L; Melamed MR
    Anal Quant Cytol Histol; 1996 Aug; 18(4):309-15. PubMed ID: 8862674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In situ hybridization using bromodeoxyuridine labelled DNA probe and RNase H.
    Kitazawa S; Kitazawa R; Gotoh A; Fujimori T; Maeda S
    Biotech Histochem; 1993 May; 68(3):137-41. PubMed ID: 8393349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells.
    Meyers FJ; Gumerlock PH; Teplitz RL; Hatcher SL; deVere White RW
    J Urol; 1989 Dec; 142(6):1599-601. PubMed ID: 2585644
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine.
    Wilson GD; McNally NJ; Dische S; Bennett MH
    Br J Radiol; 1988 May; 61(725):419-22. PubMed ID: 3382876
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunohistochemical demonstration of S-phase cells in bladder tumors by anti-bromodeoxyuridine monoclonal antibody. Using in vitro labeling method].
    Tsujihashi H; Matsuda H; Akiyama T; Kurita T; Uejima S
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):423-7. PubMed ID: 3221593
    [No Abstract]   [Full Text] [Related]  

  • 60. Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe.
    Masters JR; Bedford P; Kearney A; Povey S; Franks LM
    Br J Cancer; 1988 Mar; 57(3):284-6. PubMed ID: 3355767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.